# Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy

> **NCT05199389** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Jessa Hospital** · enrollment: 60 (actual)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DEVICE:** Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)

## Key facts

- **NCT ID:** NCT05199389
- **Lead sponsor:** Jessa Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-31
- **Primary completion:** 2023-11-15
- **Final completion:** 2028-11-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199389, "Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05199389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*